Literature DB >> 8530478

Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes.

S J Atkinson1, T Crabbe, S Cowell, R V Ward, M J Butler, H Sato, M Seiki, J J Reynolds, G Murphy.   

Abstract

Membrane-type matrix metalloproteinase (MT-MMP) messenger RNA and protein expression were shown to be elevated in human fibroblasts following treatment with concanavalin A, coincident with the induction of the ability to process progelatinase A. CHO cells transfected with the cDNA for MT-MMP were able to process both wild type progelatinase A and a catalytically inactive mutant, E375A progelatinase A. Both proenzymes were converted to a 68-kDa intermediate (reducing gels) form, but only the wild type enzyme was processed further to a 66-kDa end product. In contrast, both forms of progelatinase were processed via the 68-kDa intermediate to 66 kDa by concanavalin A-stimulated fibroblasts. Further study of the processing of E375A progelatinase A by plasma membrane preparations from concanavalin A-stimulated fibroblasts showed that addition of active gelatinase A enhanced processing to the mature form. It was concluded that cell membrane-mediated activation of progelatinase A could be via a cascade involving both MT-MMP and intermolecular autolytic cleavage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530478     DOI: 10.1074/jbc.270.51.30479

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.

Authors:  A M Tester; N Ruangpanit; R L Anderson; E W Thompson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  MT1-MMP-mediated basement membrane remodeling modulates renal development.

Authors:  Karen S Riggins; Glenda Mernaugh; Yan Su; Vito Quaranta; Naohiko Koshikawa; Motoharu Seiki; Ambra Pozzi; Roy Zent
Journal:  Exp Cell Res       Date:  2010-08-19       Impact factor: 3.905

Review 3.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

4.  TIMP-2 is required for efficient activation of proMMP-2 in vivo.

Authors:  Z Wang; R Juttermann; P D Soloway
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 5.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

6.  MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.

Authors:  Susan J Atkinson; Christian Roghi; Gillian Murphy
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

7.  DA-Raf-dependent inhibition of the Ras-ERK signaling pathway in type 2 alveolar epithelial cells controls alveolar formation.

Authors:  Haruko Watanabe-Takano; Kazunori Takano; Akemi Sakamoto; Kenji Matsumoto; Takeshi Tokuhisa; Takeshi Endo; Masahiko Hatano
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

8.  Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

Authors:  K Lehti; J Lohi; H Valtanen; J Keski-Oja
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 9.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

10.  CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.

Authors:  Hidetoshi Mori; Taizo Tomari; Naohiko Koshikawa; Masahiro Kajita; Yoshifumi Itoh; Hiroshi Sato; Hideaki Tojo; Ikuo Yana; Motoharu Seiki
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.